PREFERENCE-BASED HEALTH-RELATED QUALITY OF LIFE OUTCOMES IN CHILDREN WITH AUTISM SPECTRUM DISORDERS: A COMPARISON OF GENERIC INSTRUMENTS

摘要

BackgroundCost-effectiveness analysis of pharmaceutical and other treatments for children with autism spectrum disorders (ASDs) has the potential to improve access to services by demonstrating the value of treatment to public and private payers, but methods for measuring quality adjusted life years (QALYs) in children are understudied. No cost-effectiveness analyses have been undertaken in this population using the cost per QALY metric.